Oral vitamin K antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Oral vitamin K antagonist, covering 2017-07-31 to 2017-07-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention [Phase 3]